Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial
Akimichi Morita, Bruce Strober, A. David Burden, Siew Eng Choon, Milan J. Anadkat, Slaheddine Marrakchi, Tsen‐Fang Tsai, Kenneth B. Gordon, Diamant Thaçi, Min Zheng, Na Hu, Thomas Haeufel, Christian Thoma, Mark Lebwohl
Topics & Concepts
MedicinePlaceboClinical endpointPsoriasisAdverse effectInternal medicineRandomized controlled trialSubcutaneous injectionDermatologyAlternative medicinePathologyPsoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsDermatology and Skin Diseases